alpha alpha serine proteinase inhibitor serpin cathepsin g mast cell chymase chymotrypsin target enzymes present case man low plasma levels alpha asthma progression emphysema chronic hcv positive liver disease selective accumulation alpha hepatocytes secretory defect analogous seen pi z alpha deficiency molecular basis alpha deficiency patient characterized direct sequencing alpha genes patient father transversion exon iii causing substitution proposed cause conformational change resulting abnormal transport rer mutation NUMBER additional tested patients chronic obstructive lung disease control additional polymorphisms gene identified unrelated healthy individuals normal plasma alpha levels alpha deficiency state predispose obstructive lung disease influence course liver disease identification specific mutation allows identification heterozygotes deficiency allowing future evaluation clinical significance NUMBER antichymotrypsin NUMBER act middle aged NUMBER act NUMBER act NUMBER antitrypsin NUMBER act NUMBER act c g 229pro ala NUMBER act NUMBER act